RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Chapel Hill, NC · Durham, NC · Winston-Salem, NC · +23 more sites
3 recruiting ulcerative colitis studies with a site in Durham, NC.
Sponsor: Spyre Therapeutics, Inc.
Chapel Hill, NC · Durham, NC · Winston-Salem, NC · +23 more sites
Sponsor: Sanofi
Chapel Hill, NC · Charlotte, NC · Durham, NC · +115 more sites
Sponsor: University of North Carolina, Chapel Hill
Chapel Hill, NC · Charlotte, NC · Durham, NC · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.